Related Experiment Video

Updated: Jun 1, 2026

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery

Xinmei Wang1, Bo Yu, Yun Wu

  • 1Capital Normal University, Beijing, PR China.

Anticancer Research
|May 28, 2011
PubMed
Abstract

Insights

Lipid nanoparticles effectively deliver small-interfering RNA (siRNA) targeting cyclin-dependent kinase 4 (CDK4) to cancer cells. This novel delivery system promotes cell cycle arrest and inhibits CDK4, offering a promising cancer therapy strategy.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • Cyclin-dependent kinase 4 (CDK4) activity is a target for cancer therapy.
  • Small-interfering RNA (siRNA) offers a method to inhibit CDK4.

Purpose of the Study:

  • To develop and evaluate a lipid nanoparticle (LNP)-based delivery system for CDK4 siRNA.
  • To assess the efficacy of LNP-siRNA in cancer cells.

Main Methods:

  • CDK4 siRNA was encapsulated in a lipid nanoparticle (LNP) formulation.
  • Physical properties (size, charge) of LNP-siRNA were characterized.
  • Cellular uptake, CDK4 expression, and cell cycle arrest were evaluated in cancer cell lines.

Main Results:

  • LNP-mediated siRNA delivery enhanced cellular uptake.
  • LNP-CDK4 siRNA treatment resulted in significant G(1) cell cycle arrest.
  • Efficient down-regulation of CDK4 at mRNA and protein levels was observed.

Conclusions:

  • LNP-siRNA is a viable strategy for CDK4-based cancer therapy.
  • The developed LNP system enables efficient in vitro siRNA delivery.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers11:53

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...